TMO
THERMO FISHER SCIENTIFIC INC.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$679.40
−1.54%Year over year
Reported trailing growth
- Revenue
- +7.2%
- EBITDA
- +1.5%
- EBIT
- +4.9%
- EPS
- +7.4%
- Free cash flow
- +18.6%
- Operating cash flow
- +18.9%
Forward estimates
Based on analyst estimates
- Revenue
- +6.9%
- EBITDA
- +33.5%
- EPS
- +44.0%
Three-year CAGR
- Revenue
- -0.3%
- EBITDA
- -1.3%
- EBIT
- -1.7%
- Net income
- -1.0%
- EPS
- +0.1%
- Free cash flow
- -3.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026